How do I read and understand my Leukemia pathology report

Understanding Your Leukemia Pathology Report

I'm glad you're taking an active role in understanding your medical information. A pathology report is one of the most important documents in your leukemia diagnosis, so let me walk you through what you'll typically find and what it means.

What Is a Pathology Report?

A pathology report is a detailed analysis of cells and tissue samples taken from your bone marrow or blood. According to the NCCN Guidelines for Patients: Acute Myeloid Leukemia, a pathologist (a medical expert who analyzes cells and tissues) examines your samples and provides information about your diagnosis, the type of leukemia you have, and important biomarker testing results that guide treatment decisions.

Main Sections You'll See

1. Patient Information & Sample Details

This section identifies you, the date the sample was collected, and what type of sample was tested (bone marrow aspirate, bone marrow biopsy, or blood).

2. Clinical History

Your doctor's reason for ordering the test—usually something like "rule out leukemia" or "evaluate for AML."

3. Specimen Description

This describes what the pathologist actually received and examined. For leukemia, you might see:

• "Bone marrow aspirate and biopsy"
• "Peripheral blood smear"
• Description of color, consistency, and cellularity (how many cells are present)

4. Morphology (Cell Appearance)

This is where the pathologist describes what the cells look like under the microscope:

What to look for:

• Blast percentage: The percentage of immature white blood cells (blasts) in your bone marrow or blood. According to NCCN Guidelines, a diagnosis of AML generally requires 20% or more myeloblasts (at least 1 out of every 5 cells). However, AML can be diagnosed with any number of blasts if specific gene mutations or abnormal chromosomes are present.
• Cell maturity: Whether cells are very immature, partially mature, or nearly mature
• Abnormal features: Any unusual characteristics of the cells

Example you might see: "Increased myeloblasts comprising 35% of nucleated cells" — This means 35% of the cells examined are immature myeloid blasts, which is consistent with AML.

5. Flow Cytometry Results

This is a laboratory technique that uses special dyes and light to identify and count specific types of cells. According to the NCCN Guidelines, flow cytometry detects subtle differences between different types of blood cancers that a regular blood count cannot see.

What to look for:

• Immunophenotype: A list of biomarkers (proteins on cell surfaces) that identify what type of leukemia cells you have
• CD markers: Numbers like "CD33+, CD13+, CD34+" — these are specific proteins found on your leukemia cells
• Percentage of abnormal cells: How many of your cells have this abnormal pattern

Why it matters: Different combinations of CD markers help your doctor determine your specific leukemia subtype and which treatments might work best.

6. Cytogenetics/Karyotype

This section reports chromosomal abnormalities. According to NCCN Guidelines, genetic and biomarker tests are used to learn more about your subtype of AML, to target treatment, and to determine the likely course the cancer will take (called prognosis).

What you might see:

• Normal karyotype: "46,XX" or "46,XY" (normal number of chromosomes)
• Abnormalities: Examples include:
  • t(8;21) or t(15;17) — chromosomes that have swapped pieces
  • del(5q) — a deletion (missing piece) on chromosome 5
  • Monosomy 7 — loss of an entire chromosome 7
  • Complex karyotype — multiple abnormalities (generally indicates more aggressive disease)

7. Molecular/Genetic Mutations

This section lists specific gene mutations found in your leukemia cells. Common ones include:

• FLT3-ITD or FLT3-TKD: Mutations in the FLT3 gene
• NPM1: Nucleophosmin mutation
• CEBPA: CCAAT/enhancer-binding protein alpha mutation
• TP53: Tumor suppressor gene mutation
• IDH1/IDH2: Isocitrate dehydrogenase mutations

Why it matters: These mutations help your doctor understand how aggressive your leukemia is and which targeted therapies might be most effective.

8. Interpretation/Conclusion

This is the pathologist's summary, typically stating:

• The diagnosis (e.g., "Acute Myeloid Leukemia, NOS" or a specific subtype)
• The percentage of blasts
• Key genetic findings
• Any relevant comments about prognosis or treatment implications

Example: "Acute myeloid leukemia with t(8;21)(q22;q22.1); RUNX1-RUNX1T1. This is a favorable-risk AML."

Key Terms You'll Encounter

| Term | What It Means | |------|---------------| | Blasts | Immature white blood cells | | Morphology | The appearance and structure of cells | | Immunophenotype | The pattern of proteins (biomarkers) on cell surfaces | | Cytogenetics | The study of chromosomes and their abnormalities | | Translocation | When pieces of two different chromosomes swap places | | Deletion | When a piece of a chromosome is missing | | Mutation | A change in the genetic code of a gene | | Favorable-risk | Genetic features associated with better treatment response | | Adverse-risk | Genetic features associated with more aggressive disease |

How to Use This Information

1. Highlight key findings: Mark the blast percentage, major chromosomal abnormalities, and gene mutations
2. Write down questions: If you see terms you don't understand, write them down
3. Bring it to your appointment: Show your report to your oncologist and ask them to explain what each finding means for YOUR specific situation
4. Ask about risk stratification: Ask your doctor how these findings place you in terms of risk groups, which helps determine treatment options

Important Questions to Ask Your Doctor

• What subtype of AML (or other leukemia) do I have, and what does this mean?
• What do my genetic and chromosomal findings tell us about how my leukemia might respond to treatment?
• Are there any favorable or unfavorable prognostic factors in my report?
• How will these findings influence my treatment plan?
• Will my treatment be based on any of these specific mutations or chromosomal changes?
• Are there any clinical trials available for my specific genetic profile?

Remember

Your pathology report is a snapshot of your leukemia at one point in time. It's a crucial tool that helps your care team make informed decisions about your treatment. However, your complete clinical picture—including your age, overall health, performance status, and how you respond to initial treatment—also matters significantly in determining the best approach for you.

According to the NCCN Guidelines for Patients, you have an important role in your care. By understanding your pathology report and asking questions, you're more likely to get the care you want and feel more satisfied with your treatment decisions.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions about your specific pathology findings and treatment plan.